Leadership
Alexion is guided by a global management team of recognized industry experts who
share a common commitment to patients with ultra-rare diseases. Under their leadership,
the company is working not only to discover and develop life-changing therapies,
but also to implement the plans and infrastructure necessary to make them available
throughout the world.
Alexion benefits from the deep management, financial, medical and scientific expertise
of its Board of Directors. Members of Alexion's Board have held executive and leadership
positions in the pharmaceutical, biotechnology and health insurance industries,
as well as health systems and academia.